Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

Last updated: January 12, 2026
Sponsor: Mayo Clinic
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Osteoarthritis

Treatment

Electromagnetic Transduction Therapy (EMTT)

Clinical Study ID

NCT06696118
24-002661
  • Ages > 18
  • All Genders

Study Summary

The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Eligibility Criteria

Inclusion

Inclusion Criteria:

• Men and women with osteoarthritis of the foot and/or ankle confirmed via radiographs.

Exclusion

Exclusion Criteria:

• Pacemaker, active cancer, shrapnel, metal in eye, implantable devices that are not compatible with MRIs, concurrent foot or ankle condition or injury, prior foot or ankle surgery for osteoarthritis, steroid, platelet rich plasma, or hyaluronic acid injection within 2 months of the treatment.

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Electromagnetic Transduction Therapy (EMTT)
Phase:
Study Start date:
March 13, 2025
Estimated Completion Date:
January 31, 2027

Connect with a study center

  • Mayo Clinic in Rochester

    Rochester, Minnesota 55905
    United States

    Site Not Available

  • Mayo Clinic in Rochester

    Rochester 5043473, Minnesota 5037779 55905
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.